Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Pink Dx is an early-stage biotechnology company focused on improving women's health by developing innovative diagnostic solutions for gynecological cancers. The company aims to address the…

Pink Dx is an early-stage biotechnology company focused on improving women's health by developing innovative diagnostic solutions for gynecological cancers. The company aims to address the…
Sector: Biotechnology — women's health diagnostics
Core product: Non‑invasive vaginal‑swab test to detect endometrial (gynecologic) cancer using whole‑transcriptome sequencing and machine learning
Founded: 2022
Headcount: 11–50 employees (reported)
Known funding: Series A — reported $40M (Apr 2024) + $5M extension (Jan 2025); total reported ~$45M; total funding reported ~$61.98M
Gynecologic cancer diagnostics — improving early detection and reducing invasive procedures for endometrial cancer
2022
Biotechnology
$40,000,000
Reported Series A announced April 2024
$5,000,000
Reported additional Series A tranche in January 2025 bringing Series A proceeds to ~$45M
“Backed by life‑science investors including Catalio Capital Management, The Production Board, Mountain Group Partners, Byers Capital, Mayo Clinic, BEVC, Sandbox Industries, Blue Venture Fund and others”
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
81,000+
Open Roles
4,000+
New This Week